Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Durect Q4 EPS $(0.03) Beats $(0.05) Estimate, Sales $7.30M Beat $2.10M Estimate
Durect (NASDAQ:DRRX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 25 percent increase over losses of $(0.04) per share from the same period
Earnings Scheduled For March 7, 2022
Companies Reporting Before The Bell
• Niu Technologies (NASDAQ:NIU) is expected to report quarterly earnings at $0.21 per share on revenue of $144.02 million.
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.
DURECT Reports Dosing Of First European Patient In Phase 2b AHFIRM Study Of DUR-928 In Severe Alcohol-Associated Hepatitis
DURECT Corporation (NASDAQ:DRRX) today announced it dosed the first patient in the European Union as part of its AHFIRM randomized, double-blind, placebo-controlled, multi-center Phase 2b study to evaluate the
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Biomerica (NASDAQ:BMRA) stock increased by 10.2% to $4.95 during Wednesday's after-market session. The market value of their outstanding shares is at $61.9 million. As per the news, the Q2 earnings report came out today.
